#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2856	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2185	378.1	0	.	n	.	0	C451T	SNP	451	451	C	704	704	T	390	T,C,A,G	157,178,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2856	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2185	378.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1703	1703	T	436	T,C	183,202	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2856	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2185	378.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	423	C	347	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2856	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2185	378.1	0	HET	.	.	.	C207T,G	.	207	207	C	460	460	C	382	C,T,G	151,167,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2856	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2185	378.1	0	HET	.	.	.	C328G	.	328	328	C	581	581	C	392	C,G	226,114	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4758	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3949	360.2	0	.	n	.	0	T695C	SNP	695	695	T	1185	1185	C	348	C,A	281,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4758	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3949	360.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2461	2461	C	458	C	392	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4758	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3949	360.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3087	3087	T	434	T,G,A	363,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4758	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3949	360.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2535	2535	A	465	A,C	396,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	488	folP	855	855	100.0	folP.l15.c4.ctg.1	2040	71.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1263	1265	AGC	116;117;116	A,G;G;C	94,1;94;96	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1048	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3736	83.9	1	SNP	p	S91F	1	.	.	271	273	TTC	718	720	TTC	91;90;90	T,G;T,G;C,A	78,1;79,1;81,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1048	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3736	83.9	1	SNP	p	D95G	1	.	.	283	285	GGC	730	732	GGC	92;92;93	G;G;C	82;77;82	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1048	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3736	83.9	1	SNP	p	G95N	0	.	.	283	285	GGC	730	732	GGC	92;92;93	G;G;C	82;77;82	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	428	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1935	66.0	1	SNP	p	G45D	0	.	.	133	135	GGC	777	779	GGC	132;131;130	G;G;C	112;110;111	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	274	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1391	59.0	0	.	n	.	0	A197.	DEL	197	197	A	732	732	A	120	A	104	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3280	97.4	1	SNP	p	D86N	0	.	.	256	258	GAC	736	738	GAC	131;131;132	G;A;C	99;96;108	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3280	97.4	1	SNP	p	S87R	1	.	.	259	261	CGT	739	741	CGT	132;129;129	C;G;T	106;106;105	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3280	97.4	1	SNP	p	R87I	0	.	.	259	261	CGT	739	741	CGT	132;129;129	C;G;T	106;106;105	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3280	97.4	1	SNP	p	R87W	0	.	.	259	261	CGT	739	741	CGT	132;129;129	C;G;T	106;106;105	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3280	97.4	1	SNP	p	S88P	0	.	.	262	264	TCC	742	744	TCC	128;128;129	T,A,G;C;C,G	102,1,1;105;105,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	836	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3075	81.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1773	1775	GGC	104;104;104	G;G;C	93;92;92	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1466	1468	GCC	109;109;109	G;C,A;C	92;91,1;88	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1469	1471	ATG	108;108;107	A;T;G	96;93;91	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1481	1483	ACC	107;108;108	A;C;C	93;92;94	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1481	1483	ACC	107;108;108	A;C;C	93;92;94	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1982	1984	ACC	99;100;100	A;C;C	90;86;90	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2036	2038	GCG	100;101;101	G;C;G	87;90;89	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2036	2038	GCG	100;101;101	G;C;G	87;90;89	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2159	2161	GGT	102;102;102	G;G;T	83;78;82	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2168	2170	AGC	101;101;100	A;G;C	83;85;83	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	710	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2805	75.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2186	2188	CCG	99;99;101	C;C;G	78;78;80	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1018	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3470	87.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1756	1758	CCG	113;112;112	C;C;G,C	88;91;95,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	590	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2400	73.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	886	886	C	102	C	85	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	106	porB1a	984	324	90.24	porB1a.l15.c4.ctg.1	1527	20.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1226	1228	AAT	9;10;10	A;A;T	7;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	106	porB1a	984	324	90.24	porB1a.l15.c4.ctg.1	1527	20.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1229	1231	AAT	9;9;9	A;A;T	7;8;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	106	porB1a	984	324	90.24	porB1a.l15.c4.ctg.1	1527	20.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1253	1255	GCA	7;7;7	G;C;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	106	porB1a	984	324	90.24	porB1a.l15.c4.ctg.1	1527	20.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1276	1278	GTA	6;6;6	G;T;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	106	porB1a	984	324	90.24	porB1a.l15.c4.ctg.1	1527	20.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1285	1285	A	6	A	6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2187	84.0	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1224	1226	AGA	120;120;120	A;G;A	103;98;101	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2187	84.0	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1245	1247	GGT	121;121;121	G;G;T	102;99;100	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2187	84.0	1	SNP	p	G120K	1	.	.	358	360	AAG	954	956	AAG	132;132;131	A,C;A;G	109,1;107;105	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2187	84.0	1	SNP	p	A121N	1	.	.	361	363	AAC	957	959	AAC	130;130;129	A;A;C	107;112;107	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2187	84.0	1	SNP	p	N121D	0	.	.	361	363	AAC	957	959	AAC	130;130;129	A;A;C	107;112;107	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1978	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5654	104.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	300	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1535	58.5	1	SNP	p	V57M	1	.	.	169	171	ATG	756	758	ATG	128;128;128	A;T;G	105;101;104	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
